Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Stud Health Technol Inform ; 94: 329-35, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-15455918

RESUMO

We report on efforts to provide high-level intuitive tools that exploit commodity-based computing to facilitate real-time and distributed interactions with volumetric data. These efforts include an open source volume-rendering library, a portable volume visualization application framework, and parallel volume-rendering exploiting commodity-based hardware. We present our design and implementations, as well as examples of some of the various groups currently utilizing these tools, and discuss the tradeoffs of our developments versus existing techniques.


Assuntos
Simulação por Computador , Gestão da Informação , Interface Usuário-Computador , Fatores de Tempo
2.
Am J Physiol Heart Circ Physiol ; 279(5): H2390-8, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11045976

RESUMO

The goal of this study was to measure flux through pyruvate carboxylation and decarboxylation in the heart in vivo. These rates were measured in the anterior wall of normal anesthetized swine hearts by infusing [U-(13)C(3)]lactate and/or [U-(13)C(3)] pyruvate into the left anterior descending (LAD) coronary artery. After 1 h, the tissue was freeze-clamped and analyzed by gas chromatography-mass spectrometry for the mass isotopomer distribution of citrate and its oxaloacetate moiety. LAD blood pyruvate and lactate enrichments and concentrations were constant after 15 min of infusion. Under near-normal physiological concentrations of lactate and pyruvate, pyruvate carboxylation and decarboxylation accounted for 4.7 +/- 0.3 and 41.5 +/- 2.0% of citrate formation, respectively. Similar relative fluxes were found when arterial pyruvate was raised from 0.2 to 1.1 mM. Addition of 1 mM octanoate to 1 mM pyruvate inhibited pyruvate decarboxylation by 93% without affecting carboxylation. The absence of M1 and M2 pyruvate demonstrated net irreversible pyruvate carboxylation. Under our experimental conditions we found that pyruvate carboxylation in the in vivo heart accounts for at least 3-6% of the citric acid cycle flux despite considerable variation in the flux through pyruvate decarboxylation.


Assuntos
Ciclo do Ácido Cítrico/fisiologia , Ácido Láctico/metabolismo , Miocárdio/metabolismo , Ácido Pirúvico/metabolismo , Ácido 3-Hidroxibutírico/metabolismo , Animais , Caprilatos/farmacologia , Isótopos de Carbono , Ácido Cítrico/metabolismo , Ciclo do Ácido Cítrico/efeitos dos fármacos , Vasos Coronários/fisiologia , Ácidos Graxos não Esterificados/farmacocinética , Feminino , Glucose/farmacocinética , Infusões Intra-Arteriais , Ácido Láctico/administração & dosagem , Masculino , Oxirredução/efeitos dos fármacos , Complexo Piruvato Desidrogenase/antagonistas & inibidores , Ácido Pirúvico/administração & dosagem , Suínos , Distribuição Tecidual/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA